Citation Impact
Citing Papers
Prognostic Significance of, and Gene and MicroRNA Expression Signatures Associated With, CEBPA Mutations in Cytogenetically Normal Acute Myeloid Leukemia With High-Risk Molecular Features: A Cancer and Leukemia Group B Study
2008
Nucleic acid detection with CRISPR-Cas13a/C2c2
2017 StandoutScience
Lung Squamous Cell Carcinoma mRNA Expression Subtypes Are Reproducible, Clinically Important, and Correspond to Normal Cell Types
2010
LncRNA HOXA11-AS Promotes Proliferation and Invasion of Gastric Cancer by Scaffolding the Chromatin Modification Factors PRC2, LSD1, and DNMT1
2016 Standout
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Prognostic impact, concurrent genetic mutations, and gene expression features of AML with CEBPA mutations in a cohort of 1182 cytogenetically normal AML patients: further evidence for CEBPA double mutant AML as a distinctive disease entity
2010
ETS2 Mediated Tumor Suppressive Function and MET Oncogene Inhibition in Human Non–Small Cell Lung Cancer
2013
fastp: an ultra-fast all-in-one FASTQ preprocessor
2018 Standout
Infrared molecular fingerprinting of blood-based liquid biopsies for the detection of cancer
2021 StandoutNobel
Quantification of Free Circulating Tumor DNA as a Diagnostic Marker for Breast Cancer
2008
Effects of smoking and solid-fuel use on COPD, lung cancer, and tuberculosis in China: a time-based, multiple risk factor, modelling study
2008 Standout
Free Circulating Tumor DNA as a Diagnostic Marker for Breast Cancer
2012
EGFR Antagonists in Cancer Treatment
2008 Standout
Netting neutrophils in autoimmune small-vessel vasculitis
2009 Standout
Higher Amount of Free Circulating DNA in Serum than in Plasma Is Not Mainly Caused by Contaminated Extraneous DNA during Separation
2006
A view on drug resistance in cancer
2019 StandoutNature
Immunosensors for detection of Annexin II and MUC5AC for early diagnosis of lung cancer
2009
Chromosome Aberrations, Gene Mutations and Expression Changes, and Prognosis in Adult Acute Myeloid Leukemia
2006
Cell cycle proteins as promising targets in cancer therapy
2017 Standout
The biology and management of non-small cell lung cancer
2018 StandoutNature
Mutations in 15-hydroxyprostaglandin dehydrogenase cause primary hypertrophic osteoarthropathy
2008 Standout
Rates of drug resistance and risk factor analysis in civilian and prison patients with tuberculosis in Samara Region, Russia
2005
Lung Cancer
2008 Standout
Studies in NZB IL-10 knockout mice of the requirement of IL-10 for progression of B-cell lymphoma
2004
A cytokine-mediated link between innate immunity, inflammation, and cancer
2007 Standout
Apoptotic DNA fragments in serum of patients with muscle invasive bladder cancer: A prognostic entity
2008
Circulating cell-free and Epstein–Barr virus DNA in pediatric B-non-Hodgkin lymphomas
2010
Tumor Metastasis: Molecular Insights and Evolving Paradigms
2011 Standout
Cancer therapy monitoring in xenografts by quantitative analysis of circulating tumor DNA
2012
Influence of new molecular prognostic markers in patients with karyotypically normal acute myeloid leukemia: recent advances
2007
Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
2013 Standout
The Emerging Role of “Liquid Biopsies,” Circulating Tumor Cells, and Circulating Cell-Free Tumor DNA in Lung Cancer Diagnosis and Identification of Resistance Mutations
2017
Current and future perspectives of liquid biopsies in genomics-driven oncology
2018 Standout
Acute myeloid leukaemia
2006
RB and cell cycle progression
2006 Standout
Inherited Predisposition to Acute Myeloid Leukemia
2014
Role of cell‐cycle regulators in lung cancer
2005
Cell-free nucleic acids as biomarkers in cancer patients
2011 Standout
Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases
2009 Standout
Circulating Nucleic Acids in Plasma and Serum
2008
A census of mitotic cancer genes: new insights into tumor cell biology and cancer therapy
2006
Aberrant Methylation of the Maspin Promoter Is an Early Event in Human Breast Cancer
2004
The prognostic value of KRAS mutated plasma DNA in advanced non-small cell lung cancer
2012
A Translational View of the Molecular Pathogenesis of Lung Cancer
2007
Cyclin D as a therapeutic target in cancer
2011
On the Dependency of Cellular Protein Levels on mRNA Abundance
2016 Standout
Common genetic variants at the 11q13.3 renal cancer susceptibility locus influence binding of HIF to an enhancer of cyclin D1 expression
2012 StandoutNobel
Liquid biopsies come of age: towards implementation of circulating tumour DNA
2017 Standout
Nucleosomal DNA Fragments in Autoimmune Diseases
2006
An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
2014 Standout
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
2013 Standout
Gene expression profiling in single cells within tissue
2005
The redox state of the lung cancer microenvironment depends on the levels of thioredoxin expressed by tumor cells and affects tumor progression and response to prooxidants
2008
Cell cycle, CDKs and cancer: a changing paradigm
2009 Standout
The molecular landscape of head and neck cancer
2018 Standout
Secretory Mechanisms and Intercellular Transfer of MicroRNAs in Living Cells
2010 Standout
Cell free DNA detected by a novel method in acute ST-elevation myocardial infarction patients
2010
Epigenetic modifications and human disease
2010 Standout
Unique microRNA molecular profiles in lung cancer diagnosis and prognosis
2006 Standout
Circulating nucleic acids (CNAs) and cancer—A survey
2006
Heterogeneity within AML with CEBPA mutations; only CEBPA double mutations, but not single CEBPA mutations are associated with favourable prognosis
2009
S100 proteins in mouse and man: from evolution to function and pathology (including an update of the nomenclature)
2004
Cell-free DNA in maternal plasma and serum: A comparison of quantity, quality and tissue origin using genomic and epigenomic approaches
2016
Maftools: efficient and comprehensive analysis of somatic variants in cancer
2018 Standout
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
2009 Standout
Clinical Relevance of Circulating Nucleosomes in Cancer
2008
NAD+-linked 15-hydroxyprostaglandin dehydrogenase (15-PGDH) behaves as a tumor suppressor in lung cancer
2004
Slaying RAS with a synthetic lethal weapon
2010 StandoutNobel
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
Proteomic Changes Resulting from Gene Copy Number Variations in Cancer Cells
2010
Plasma cell‐free DNA in ovarian cancer
2010
The Myofibroblast
2007 Standout
Elevated nuclear maspin expression is associated with microsatellite instability and high tumour grade in colorectal cancer
2005
Blockade of Wnt-1 signaling induces apoptosis in human colorectal cancer cells containing downstream mutations
2005
An Overview of Lung Cancer Genomics and Proteomics
2005
Genome-wide analysis of DNA copy number changes and LOH in CLL using high-density SNP arrays
2006
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines
2008 Standout
KRAS Mutations and Sensitivity to Epidermal Growth Factor Receptor Inhibitors in Colorectal Cancer: Practical Application of Patient Selection
2009
Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL)
2006 Standout
Pretreatment cytogenetics add to other prognostic factors predicting complete remission and long-term outcome in patients 60 years of age or older with acute myeloid leukemia: results from Cancer and Leukemia Group B 8461
2006
Genomic and Proteomic Profiling of Lung Cancers: Lung Cancer Classification in the Age of Targeted Therapy
2005
Overexpression of the ETS-Related Gene, ERG, Predicts a Worse Outcome in Acute Myeloid Leukemia With Normal Karyotype: A Cancer and Leukemia Group B Study
2005
Chromosomal translocations are associated with poor prognosis in chronic lymphocytic leukemia
2005
Acute Myeloid Leukemia
2015 Standout
Long Noncoding RNA and Cancer: A New Paradigm
2017 Standout
Potential Clinical Significance of a Plasma-Based KRAS Mutation Analysis in Patients with Advanced Non–Small Cell Lung Cancer
2010
Acute Myeloid Leukemia With IDH1 or IDH2 Mutation
2010
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
2009 Standout
Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: are we ready for a prognostically prioritized molecular classification?
2006
FAT10 mediates the effect of TNF-α in inducing chromosomal instability
2011
Double CEBPA mutations, but not single CEBPA mutations, define a subgroup of acute myeloid leukemia with a distinctive gene expression profile that is uniquely associated with a favorable outcome
2009
Cell-Free Circulating DNA: Diagnostic Value in Patients With Testicular Germ Cell Cancer
2008
Gold Nanoparticles in Chemical and Biological Sensing
2012 Standout
Quantitative analysis of cell-free DNA in the plasma of gastric cancer patients
2012
Cancer treatment and survivorship statistics, 2016
2016 Standout
Aurora B Overexpression Causes Aneuploidy and p21Cip1 Repression during Tumor Development
2015
Cancer treatment and survivorship statistics, 2019
2019 Standout
Long non-coding RNA NEAT1 promotes non-small cell lung cancer progression through regulation of miR-377-3p-E2F3 pathway
2016
Circulating Mitochondrial Nucleic Acids Have Prognostic Value for Survival in Patients with Advanced Prostate Cancer
2007
The favorable impact of CEBPA mutations in patients with acute myeloid leukemia is only observed in the absence of associated cytogenetic abnormalities and FLT3 internal duplication
2009
Predictive Utility of Circulating Methylated DNA in Serum of Melanoma Patients Receiving Biochemotherapy
2005
High meningioma 1 (MN1) expression as a predictor for poor outcome in acute myeloid leukemia with normal cytogenetics
2006
Liquid Biopsies: Genotyping Circulating Tumor DNA
2014 Standout
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
2016 Standout
Integrated microfluidic bioprocessor for single-cell gene expression analysis
2008 StandoutNobel
Works of Daniel Ratschiller being referenced
Overexpression of aurora B kinase (AURKB) in primary non-small cell lung carcinoma is frequent, generally driven from one allele, and correlates with the level of genetic instability
2005
Origin and prognostic value of circulating KRAS mutations in lung cancer patients
2007
Cyclin D1 in non-small cell lung cancer: A key driver of malignant transformation
2006
Expression profiling of primary non-small cell lung cancer for target identification
2002
S100A2 is strongly expressed in airway basal cells, preneoplastic bronchial lesions and primary non-small cell lung carcinomas
2004
Maspin – the most commonly-expressed gene of the 18q21.3 serpin cluster in lung cancer – is strongly expressed in preneoplastic bronchial lesions
2003
A high-resolution allelotype of B-cell chronic lymphocytic leukemia (B-CLL)
2002
Cyclin D1 Overexpression in Bronchial Epithelia of Patients With Lung Cancer Is Associated With Smoking and Predicts Survival
2003
Circulating Deoxyribonucleic Acid As Prognostic Marker in Non–Small-Cell Lung Cancer Patients Undergoing Chemotherapy
2004
Risk Assessment in Patients with Acute Myeloid Leukemia and a Normal Karyotype
2005